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D
iabetic nephropathy (DN) is a grave complicat t tion of both types of diabetes. In most parts of the world DN has become the most common cause of endtstage renal disease. 1, 2 The prevalence of DN and its complications is expected to rise as the incidence of diabetes increases worldwide, especially in developing countries. 3 The earliest clinical sign of DN is an increase in urinary albumin excretion that progresses to overt proteinuria and then to renal failure at a rate of 2% to 3% per year. 4 The mortality rate increases significantly as the stage of albuminuria worsens. 5 Multiple risk factors interact in the development and progression of albumint t uria including hypertension, glycemic control, diabetes duration, dietary protein overload and genetic predispot t sition. 6, 7 Other less consistent factors like smoking, hyt t
Prevalence and determinants of albuminuria in a cohort of diabetic patients in Lebanon
Nadine Taleb percholesterolemia, obesity and anemia have also been associated with a higher risk of albuminuria. 8 There is some variability in the prevalence of albut t minuria and the degree of contribution of each of its risk factors among different diabetic populations. Few data are available about the extent of this major health probt t lem in the Middle East generally and in Lebanon spet t cifically. Such information is needed because screening for DN and its risk factors allows for the introduction of early interventions to slow or reverse its progression and decrease the rate of its complications. 6, 9, 10 The aim of the present study was to determine the prevalence of albuminuria and its major risk factors in a cohort of Lebanese diabetic patients. The study was conducted at the American University of Beirut Medical Center BACKGROUND AND OBJECTIVES: Few data are available on the extent of albuminuria in diabetic populations in the Middle East generally and in Lebanon specifically. We conducted this study to determine the prevalence of albuminuria and its major risk factors in a cohort of diabetic patients in Lebanon. PATIENTS AND METHODS: Diabetic patients followed in the outpatient department at the American University of Beirut Medical Center (AUBMC) were included in a prospective observational study. AUBMC is a tertiary referral center and the outpatient department typically handles patients of low socioeconomic status with ad--vanced disease. Patients were classified according to their urinary albumin-to-creatinine ratio (ACR) as having normoalbuminuria (ACR<30 mg/g creatinine), microalbuminuria (ACR=30 to <300 mg/g creatinine), or macro--albuminuria (ACR ≥300 mg/g creatinine). The three groups were compared to analyze the association between albuminuria and its risk factors. In addition, independent predictors of albuminuria were determined using multivariate logistic regression and presented as an odds ratio. RESULTS: Microalbuminuria and macroalbuminuria were present in 33.3% and 12.7% of 222 patients (mean age 56.4 years, mean deviation of diabetes 8.6 years, 58.7% women, 43.8% obese), respectively. Factors signifi--cantly associated with microalbuminuria included glycemic control, insulin use, and total and LDL cholesterol. Those associated with macroalbuminuria included in addition to glycemic control and insulin use, duration of diabetes, hypertension, elevated mean arterial pressure (MAP), and presence of neuropathy, retinopathy and peripheral vascular disease by bivariate analysis. Only glycemic control was an independent risk factor for both in addition to MAP and retinopathy for macroalbuminuria by multivariate analysis. CONCLUSION: Albuminuria is highly prevalent among this cohort of diabetic patients in Lebanon. Both glyce--mic control and blood pressure need to be better targeted in its management.
(AUBMC), a major referral center for patients from dift t ferent parts of Lebanon.
PATIENTS AND METHODS
This report is an analysis of crosstsectional data taken at recruitment for a prospective, observational study involving patients who come regularly to the diabetes clinic in the outpatient department (OPD) of AUBMC. The OPD is a lowtbudget clinic and as such, the patient population is of a low socioeconomic status with a usut t ally poor educational level. The methods have been det t scribed in detail elsewhere along with the epidemiology of this cohort. 11 In this clinic, patients are assessed by the clinical fellows in the division of endocrinology and metabolism under the supervision of an endocrinolot t gist. Patients were eligible if they could be followed for three consecutive years. Exclusion criteria included gest t tational diabetes mellitus, age <18 years and inability to complete the laboratory data, retinal exam and followt up visits needed. Patients were recruited consecutively until the target number was reached.
A complete history was taken including known duration of disease, smoking status, and medications used, in addition to a complete physical examination with measurements of height, weight, and blood prest t sure. Microvascular complications were assessed and defined in the following manner: albuminuria was ast t sessed by collecting a morning urine sample to calcut t late the albuminttotcreatinine ratio (ACR). Patients were classified according to ACR as having microalt t buminuria (ACR=30 to <300 mg/g creatinine) and macroalbuminuria (ACR ≥300 mg/g creatinine).
Patients with normoalbuminuria were compared to those with microt and macroalbuminuria. Retinopathy was assessed by an ophthalmologist who performed a dilated slit lamp fundus exam. Neuropathy was ast t sessed by symptom history and/or the finding of det t creased pressure sensation by the monofilament test. Macrovascular complications were considered present or absent according to the history provided by the pat t tient and a review of the medical chart. A subject was considered to have coronary artery disease (CAD) if there was a history of a previous coronary event, int t cluding angina or myocardial infarction or a coronary artery intervention (angioplasty or coronary bytpass surgery). Peripheral vascular disease (PVD) included any typical history of lower extremity claudication, the finding of decreased arterial pulses by physical exam, revascularization procedure or radiological evidence of peripheral arterial disease. Cerebrovascular disease int t cluded a history of transient ischemic attack or stroke diagnosed by a physician regardless of absence of residt t ual neurological deficit on physical exam. Patients were considered hypertensive if they were already receiving antihypertensive medications or if they were found in the clinic to have elevated blood pressure (SBP >130 mm Hg, DBP >80 mm Hg) and mean arterial pressure was calculated for each patient. The use of angiotensint converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) was also assessed in the patients according to hypertension and albuminuria status. An electrocardiogram was obtained on all pat t tients. Fasting venous blood was sampled in all patients from the antecubital vein for the measurement of glyt t cated hemoglobin (HbA 1c ), serum glucose, creatinine, total cholesterol, LDLtcholesterol, HDLtcholesterol and triglycerides. Based on the American Diabetes Association 2007 recommendations, subjects were considered to have good control of their glucose levels if their HbA 1c was ≤7%. Serum creatinine was considt t ered to be normal if it were ≤1.4 mg/dL in females and ≤1.5 mg/dL in males. All venous blood and urinary tests were collected and performed at the central labot t ratory of AUBMC using standardized automated techt t niques. All laboratory testing was done at AUBMC under similar conditions with the following methodt t ology: HbA 1c by HPLC (BiotRad); urine ACR by the Tinatquant albumin test and immunoturbidimetric assay (Hitachi 912 analyzer, Roche Diagnostics); set t rum creatinine by the Jaffe method using the kinetic, ratetblanked and compensated assay (Hitachi 912 analyzer, Roche Diagnostics); total cholesterol, HDLt cholesterol and triglyceride by Hitachi 912 analyzer (Roche Diagnostics). The study was approved by the Institutional Review Board of AUBMC in accordance with the Helsinki Declaration and all patients included in this study signed a written informed consent.
Data are reported as mean±standard deviation, or as absolute numbers and percentages. Based on their ACR ratio, subjects were divided into 3 categories: normoalbuminuria, microalbuminuria and macroalt t buminuria with cuttoffs as described above and comt t parisons were made against the normoalbuminuria group. The associations between albuminuria and the different characteristics of the study population were performed as bivariate analyses using the chitsquare test for categorical variables or tttest for metric varit t ables and onetway ANOVA for variables with multiple levels. Factors that showed a significant association with either microalbuminuria and macroalbuminuria in a bivariate analysis were entered into a logistic regression to identify the independent risk factors for the development of either microalbuminuria or macroalbuminuria. However, MAP was used instead of SBP and DBP because the linearity between these two variables removes their potential effect. The ret t sults are presented as odds ratios with 95% confidence intervals. A P value <.05 was considered to be signifit t cant. Statistical Software Package SPSS (version 15.0) was used.
RESULTS
Of 313 patients originally recruited between August 2005 and April 2007, 222 (71%) completed all the ret t quirements of the study including the lab tests, medical interview, physical and comprehensive ophthalmologic exam and electrocardiogram. The mean age of subjects was 56.4±11.7 years. One hundred thirtyttwo (59.4%) were female and 208 (93.6%) had type 2 diabetes. The mean duration of disease at the time of recruitment was 8.6±6.9 years. Ninetytseven (43.8%) patients were obese (BMI ≥30) and 78 (35%) were current smokt t ers. At the time of recruitment, twotthirds of subjects had an uncontrolled HbA 1c of >7%. Hypertension was present in 118 (53.2%) of patients, of whom 83% were receiving either an ACEI or an ARB. Normal ACR was present in 54.0% of patients. Renal function was assessed by serum creatinine levels and was normal in the normoalbuminuria group. Elevated serum creatit t nine levels were found in 2.5% and 1.5% of the microalt t buminuria and macroalbuminuria groups, respectively (data not shown). Data are mean±SD or numbers and percentages; P value compares microalbuminuria with normoalbuminuria; P ´ value compares macroalbuminuria with normoalbuminuria
The rate of microalbuminuria was 33%. In the bivart t iate analysis, total and LDL cholesterol (but not HDL cholesterol or tryglyercides), and insulin use and poor glycemic control (elevated HbA 1c ) were associated with microalbuminurea (Table 1 ). In the multivariate analyt t sis, only HbA 1c was found to be an independent risk factor for microalbuminuria ( 
DISCUSSION
This study found a high rate of albuminuria in this cohort of diabetic patients at a tertiary medical center in Lebanon. The prevalence of 33.2% and 12.7% for microt and macroalbuminuria, respectively, is higher than that reported for the UKPDS (United Kingdom Prospective Diabetes Study) population, where the prevalence was 25% and 5% for micro and macroalt t buminuria, respectively. 5 Of note is that a higher ACR range (50t299 mg/gram creatinine) for defining mit t croalbuminuria and a slightly higher mean duration of disease were reported in the UKPDS group than in our patients. It may be argued that the prevalence of albuminuria may be overestimated in our subjects because it was based on a single sample of urinary ACR. However, our rates were also higher than a diat t betic population from Chennai, India where, as in our study, the diagnosis of albuminuria was based on a single ACR of greater than 30 mg/g creatinine. 12 One explanation for the higher rate may be that acute hyt t perglycemia increased the rate of microalbuminuria, especially since twotthirds of our patients had poor glycemic control, as defined by HbA 1c . Nevertheless, none of these arguments accounts for the higher prevt t alence of macroalbuminuria. A likely explanation may be the long duration of the disease and the poorer state of control among this cohort with low socioeconomic status. Genetic predisposition may also play a role.
The risk factors for diabetic kidney disease in this study were in accordance with the known traditional risk factors, especially for macroalbuminuria. Thus, glyt t cemia, BP control, the presence of other microvascular disease, and duration of disease were significant risk factors for macroalbuminuria in our subjects. 8 Of these factors, only glycemic control, as assessed by HbA 1c , reached statistical significance when restricting analysis to patients with microalbuminuria. The association bet t tween microalbuminuria and glycemia was very strong (P<.001) as compared to that with macroalbuminuria (P=.03), again emphasizing the more direct relationship between poor glycemic control and microalbuminuria. Acute hyperglycemia will increase glomerular filtration rate and intraglomerular pressure, causing an increased leakage of microalbumin.
Surprisingly, there was no association between mit t croalbuminuria and blood pressure control. One post t sible explanation is poor glycemic control (rather than blood pressure) being the main driving factor of microt t albuminuria for this group. Another explanation is that 83% of subjects with hypertension were taking ACEIs or ARBs, possibly normalizing albumin excretion.
Other risk factors associated with microalbuminuria were total serum cholesterol and LDLtC. One postut t lated mechanism for the link between hyperlipidemia and nephropathy is lowtgrade inflammation. 13 This eft t fect was not seen among the macroalbuminuria group, possibly because of the small sample size, with only 28 patients in this study having macroalbuminuria.
The presence of a microvascular complication puts the subject at high risk of having other diabetic comt t plications. 8 Retinopathy is a welltestablished risk fact t tor in type 1 diabetes, and remains a strong predictor of nephropathy in type 2 diabetes, although other fact t tors such as genetics and hypertension may attenuate this relationship.
14 There was a trend for an association with retinopathy in the microalbuminuria group, witht t out reaching significance again possibly because of the acute hyperglycemia being the main determinant in this group. Macrovascular disease is also associated with albuminuria, but less so than microvascular complicat t tions and in this study only PVD was associated with macroalbuminuria. One explanation is the lower rate of macrovascular complications in general, and thus, numt t bers did not reach statistical significance. Furthermore, the diagnosis of CAD was based on known disease by history or ECG findings and may have been underest t timated.
Less welltestablished risk factors that were not sigt t nificant in this study include age, smoking and obesity. A higher BMI was associated with a higher risk of chronic kidney disease in some studies, unlike in ours. This might be due to poor glycemic control favoring weight loss in our patients. 15 A recent study found the association to be significant, specifically with waist cirt t cumference in diabetic patients, a variable not assessed in our cohort. 16 Smoking is a risk factor for the develt t opment and progression of albuminuria. 17, 18 Among our patients with microt or macroalbuminuria, higher percentages were either current or extsmokers without reaching statistical significance. Insulin use was also associated with albuminuria (both micro and macro). However, this relationship disappears in the logistic regression. Therefore, insulin use was probably a cont t founding marker of very poor glycemic control and duration of disease. Only 20% of patients were taking insulin, whereas 68% had HbA 1c above target.
In the logistic regression analysis, the variable that remained an independent predictor of both groups was HbA 1c , which is in accordance with other studies. 12 Thus, glycemic control is a crucial target in preventt t ing diabetic kidney disease. In addition, blood pressure control (as represented by MAP) and retinopathy ret t mained independently associated with macroalbumint t uria. Blood pressure control, a welltknown risk factor, remains a strong predictor, because the use of ACEIs or ARBs for the hypertensive group is unlikely to have totally reversed the macroalbuminuria, if already existt t ing. As a more advanced stage of diabetic nephropathy, macroalbuminuria is also expected to be associated with advanced complications of DM such as retinopathy.
To our knowledge, there are no published estimates on the prevalence of DN or its predictors among diat t betic subjects in Lebanon. The high prevalence found may be an overestimation of the true prevalence, as mentioned, first because microalbuminuria was based on a single ACR determination. Second, AUBMC is a tertiary care center with a patient population that has a high level of morbidity. Third, the OPD, serves pat t tients from a low socioeconomic background who prest t ent late into their disease and are undertreated. Even though this study does not estimate the community prevalence of albuminuria, the high levels found in our patient population call for urgent action because of the known risk to progression into renal failure and develt t opment of CAD. 19 This study may have overestimated the extent of microalbuminuria and thus the results are not generalizable to the overall community. The small sample size may have missed certain associations, espet t cially with macroalbuminuria. Finally certain predictors were not assessed in this study like genetic predisposit t tion to DN and dietary protein intake. However, risk factors found were in accordance with previous reports. Furthermore, protein intake is more important in the progression than actual development of albuminuria and is not expected to be an important risk factor in our population. The diet in Lebanon among middletaged subjects tends to remain 'Mediterranean' , which is not very high in protein, especially animal protein.
This study is the first to measure albuminuria rates in a tertiary medical center in Lebanon and to correlate it with diabetic risk factors. The very high rates found necessitate further investigation into potential causes. The 3tyear followtup data, once available, will provide a better evaluation of this health problem. Nevertheless, the main predictors found so far, HbA 1c and BP levels, need to be tightly controlled to minimize diabetic albut t minuria with its known complications.
Disclosure
The epidemiology of type 2 diabetes in our cohort has been
